TGA Updates Guidance on the Testing of Biological Medicines

Australia – TGA set to accept medical device assessments from Singapore’s HSA

The Therapeutic Goods Administration (TGA), Australia’s medical device market regulator, has announced that it now recognizes Singapore’s Health Sciences Authority (HSA) as a comparable...
Topical Drug Products for Cutaneous Application: Human Safety Assessment Guidance

USA – FDA finalizes which clinical decision software functions it regulates

The US Food and Drug Administration (FDA) announced that it has finalized guidance on which clinical decision software (CDS) functions it regulates as a...

Europe – European Commission Publishes Directive on the Liability of Artificial Intelligence Systems

On September 28, 2022, the European Commission published its long-promised proposal for an AI Liability Directive.  The draft Directive is intended to complement the...

USA – FDA will begin accepting breakthrough devices for TAP pilot in 2023

The US Food and Drug Administration (FDA) will start accepting products into its total product lifecycle advisory program (TAP) pilot starting in January. The...

USA – US FDA sets some steep increases for 2023 medical device user fees

The US Food and Drug Administration announced that it has set medical device user fees for fiscal year 2023. Medical device manufacturers and importers seeking...

UK – MHRA and NICE awarded £1.8m to explore regulation of digital mental health...

The healthcare sector has seen a considerable increase in the number of digital mental health tools made available in recent years. Despite this improvement...

USA – FDA finalizes guidances on device post-approval studies, postmarket surveillance

The US Food and Drug Administration (FDA) on 7 October released two final guidances to assist manufacturers of moderate- to high-risk medical devices to...

Europe – Cyber Security

The increasing number of connected medical devices and ongoing digitisation in healthcare brings new market opportunities for the manufacturer and, more importantly, improvements in patient...

Europe – Data generated from ‘Off-Label’ Use of a device under the EU Medical...

‘Off label use’ is mentioned within the Medical Device Regulation (MDR) in Annex XIV Part B, in the context that manufacturers should proactively identify...
TEAM-NB : Survey on NBs applications against IVD new regulation

Europe – Best Practice Guidance for the Submission of Technical Documentation under Annex...

This best practice guidance document has been developed by members of Team NB who have reviewed the best practice guidance documents submitted by individual...

NOS PROCHAINES FORMATIONS